Pretreatment increases liver transplant survival in rats

June 30, 2003

Pretreating transplanted livers with the immune molecule interleukin-6 (IL-6) dramatically increased survival of rats receiving organs with fatty degeneration--a common condition in humans that typically reduces transplant viability. The results suggest a means of making it possible to use a higher percentage of available donor livers for transplantation in humans. With over three times as many Americans needing transplants as there are available donor livers, an effective approach to increasing the number of viable donor organs would help narrow the gap between demand and supply.

Steatosis, or fatty liver degeneration, is present in between 13 and 50 percent of donor livers. Fat may accumulate in the liver in association with obesity, diseases such as diabetes mellitus, and heavy drinking. Donor livers with steatosis are more likely to function poorly or fail after transplantation. With the increase in obesity in this country, the prevalence of steatosis in donor livers is expected to increase. A multi-center team of scientists found that adding the cytokine or cell-signaling molecule interleukin-6 (IL-6) to the solution in which a donor liver is stored before transplantation significantly increases post-transplant survival of rats receiving organs with fatty degeneration. Bin Gao, M.D., Ph.D., at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), led the scientific team which included investigators at The Johns Hopkins University School of Medicine, Baltimore, MD (supported in part by a research grant from NIH's National Institute on Diabetes and Digestive and Kidney Diseases) and the University of Science and Technology of China, Hefei, China.

NIAAA Director Ting-Kai Li, M.D. said, "This study is an example of how our knowledge at a molecular level of how the immune system functions to protect against tissue damage can be exploited to develop strategies for dealing with important clinical problems. The work gives us a clue for future treatment and enhances our understanding of the mechanisms of liver damage, and the protection afforded by IL-6, after transplantation."

IL-6, one of the immune system's complex network of signaling molecules, is known to protect against liver injury in a variety of conditions. In this study, scientists took either healthy livers from lean rats or steatotic livers (livers with fatty degeneration) from genetically obese rats and transplanted them into lean recipient rats. All of the recipients of livers from the lean rats survived (10 of 10). Thirty percent (3 of 10) of the recipients of the steatotic livers stored in standard solution survived. The addition of IL-6 to the preservative solution increased the survival rate of rats receiving steatotic livers to 91.7 percent (11 out of 12). Results were similar whether the organs were stored in the standard preservative used in transplantation (University of Wisconsin or UW solution) or normal saline solution, suggesting that the effect of IL-6 was direct and not the result of interactions with components in the UW solution.

The team compared the post-transplant condition of the organs by microscopic tissue examination (histology) and by measuring levels of liver enzymes that reflect liver function. Steatotic, but not lean, transplanted livers showed massive cell death (necrosis). Steatotic livers preserved in solution with IL-6, however, showed no significant necrosis. Results from liver enzyme tests revealed similar differences: Enzyme levels with IL-6-treated steatotic livers were closer to levels seen in the lean livers and significantly lower than those seen in untreated fatty livers.

The investigators also looked at the mechanisms of tissue damage. Previous research has suggested that after blood circulation is restored to a transplanted liver, loss of cells lining the sinuses of steatotic livers is a key first step in the subsequent damage. Fine capillary blood circulation (microcirculation) is impaired. In both cases, IL-6 protected against these destructive changes.

Cytokines like IL-6 act by setting off a cascade of other signaling molecules. A key effect of IL-6 in particular is activation of a cell survival signal molecule, STAT3. Results from this study confirmed that IL-6 increased and prolonged STAT3 activation. In practical terms, the authors point out, adding IL-6 to a preservative solution before transplantation is likely to require less IL-6 and less likely to cause side effects than giving IL-6 to transplant recipients.

According to the paper, in late 2002, 17,329 American patients were on the United Network for Organ Sharing waiting list for liver transplantation. At the same time, only 5,181 donor organs were available. The increasing rate of obesity in this country could increase, rather than decrease, the shortfall in viable organs.
-end-
The article by Sun, Z., Klein, A.S., Radaeva, S., Hong, F., El-Assal, O., Pan, H.-N., Jaruga, B., Batkai, S., Hoshino, S., Tian, Z., Kunos, G., Diehl, A. M., and Gao, B. appears in Gastroenterology, Volume 125, pages 202-215, 2003.

For an interview with Dr. Gao, please telephone the NIAAA Press Office.

The National Institute on Alcohol Abuse and Alcoholism, a component of the National Institutes of Health, U.S. Department of Health and Human Services, conducts and supports approximately 90 percent of U.S. research on the causes, consequences, prevention, and treatment of alcohol abuse, alcoholism, and alcohol problems and disseminates research findings to science, practitioner, policy making, and general audiences.

NIH/National Institute on Alcohol Abuse and Alcoholism

Related Liver Transplantation Articles from Brightsurf:

Study reveals improving survival rates after liver transplantation in the UK
In the past two decades, death rates after liver transplantation have dropped by more than half in the UK, according to a recent analysis of almost 10,000 liver transplant recipients published in BJS (British Journal of Surgery).

Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.

US study reports dramatic reduction in likelihood of liver transplantation in patients with hepatoce
ILC 2018: Although hepatocellular carcinoma is now the leading indication for liver transplantation in the USA, the probability of patients receiving a transplant has declined significantly in recent years.

HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs
HCV-related liver transplantation and post-transplant survival rates in Europe have improved rapidly in the era of direct-acting antiviral drugs.

Alcoholic liver disease replaces hepatitis C infection as the leading cause of liver transplantation in patients without hepatocellular carcinoma in the USA
Two independent US studies confirm that, from 2016 onwards, alcoholic liver disease has led to more liver transplants than hepatitis C infection in patients without hepatocellular carcinoma (HCC).

The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.

Researchers develop new technique to model transplantation of the human liver
A novel technology developed by researchers at the Massachusetts General Hospital enables the model-ing of human liver transplantation in an experimental setting.

New method creates liver bioscaffolds with intact ECM for reseeding and transplantation
Researchers have reported a method for successfully removing the cellular material from whole human livers while retaining the organ's three-dimensional structure and extracellular matrix (ECM) components.

Routine hospital tool found to predict poor outcomes after liver transplantation
A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai.

Critically ill children can still undergo liver transplantation and survive
Advancements in critical care make it possible for even the sickest children to successfully undergo liver transplantation.

Read More: Liver Transplantation News and Liver Transplantation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.